All In Biotech

Drug Trial Radar · NCT02351960

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole

Last checked: Nov 20, 2026Latest source record: Oct 4, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

296

Actual

Start

Mar 19, 2015

Primary completion

Jun 22, 2016

Study completion Jul 13, 2016

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Jan 30, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effectiveness of symptom control in gastroesophageal reflux disease (GERD) participants following treatment with dexlansoprazole.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

  • DexlansoprazoleDrug

    Dexlansoprazole capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of 24-Hour Heartburn and Acid Regurgitation-Free Days in Non-Erosive Reflux Disease (NERD) ParticipantsTime frame: Up to Week 4
  2. Percentage of 24-Hour Heartburn and Acid Regurgitation-Free Days in Erosive Esophagitis (EE) ParticipantsTime frame: Up to Week 8

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • Site not named

    Shatin, New Territories, Hong Kong

  • Site not named

    Gyeonggi-do, South Korea

  • Site not named

    Gyeonggi-do, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Kaoshiung, Taiwan

  • Site not named

    Taichung, Taiwan

  • Site not named

    Tainan, Taiwan

  • Site not named

    Taipei, Taiwan

  • Site not named

    Taoyuan, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.